We show that aromatase expression is significantly higher in BRCA1 mutation carriers, in patients who had experience breast cancer but also in women who had a high risk for breast cancer and had prophylactic removal of their breast tissue. The gene discussed is CYP19A1; the disease is breast carcinoma.